Results

Total Results: 289 records

Showing results for "sedation".

41. Benefits and Harms of Routine Preoperative Testing: Comparative Effectiveness | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/preoperative-testing/research
    December 01, 2019 - of both adults and children undergoing surgical and other procedures requiring either anesthesia or sedation

42. Untitled (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/suicide-prevention_research-protocol.pdf
    December 23, 2015 - Untitled Source: www.effectivehealthcare.ahrq.gov Published online: December 23, 2015 Evidence-based Practice Center Systematic Review Protocol Project Title: Suicide Prevention I. Background and Objectives for the Systematic Review Despite advances in the diagnosis and treatment of major mental disord…

43. Fraenkel (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/fraenkel.pdf
    December 26, 2012 - http://www.effectivehealthcare.ahrq.gov/index.cfm) � • Sedation

44. Migraine-Emergency Executive (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/migraine-emergency_executive.pdf
    November 01, 2012 - acute migraine Intervention Generic Name Trade Name(s) Mode of Administration Agents for Procedural Sedation … The results are presented by adverse effect categories (e.g., sedation, dizziness, vomiting). … Sedation/Somnolence Twenty-five studies reported on the development of sedation/somnolence, including … The risk of developing sedation/ somnolence as a result of taking a placebo was 5 percent (95% CI, 2 … The risk of experiencing sedation following administration of metoclopramide and prochlorperazine was

45. Drowning | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/drowning
    Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

46. Engaging-Caregivers-Appendix-B (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/engaging-caregivers-appendix-b.xlsx
    January 08, 2024 - anticipated to be in the ICU for more than 48 hours; 2) Patients who had had any procedure(s) that required sedation … positive on the Confusion Assessment Method in the ICU tool; (4) Patients who had a Richmond Agitation-Sedation

47. Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
    April 01, 2020 - Duloxetine resulted in a large, dose- dependent, increase in sedation (SOE: Moderate to Low). … Additionally, pregabalin resulted in large increases in risk of peripheral edema and sedation (SOE: … Duloxetine also resulted in increased sedation, but lower doses did reduce the risk. … and gabapentin resulted in moderate to large increases in blurred vision, dizziness, weight gain, sedation … Additionally, pregabalin resulted in large increases in risk of peripheral edema and sedation.

48. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/migraine-emergency_research-protocol.pdf
    July 18, 2011 - Addressing sedation as an adverse event. … Sedation/somnolence b. Dizziness c. Restless legs/akathisia d. Anxiety e. Vomiting f. … Sedation/somnolence 2. Dizziness 3. Restless legs/akathisia 4. Anxiety 5. Vomiting 6. … in the ED, Visual Analog Scale score at discharge, and relapse after 48 hours) and safety (e.g., sedation … interventions for acute migraine Generic name Trade name(s) Mode of administration Agents for procedural sedation

49. Tinnitus Executive (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tinnitus_executive.pdf
    August 01, 2013 - characteristics, and symptoms Comparative e�ectiveness of treatment interventions Worsening of tinnitus Sedation … subjective loudness, quality of life, tinnitus severity, adverse effects (worsening of tinnitus, sedation … subjective loudness, quality of life, return to “normal” work, adverse effects (worsening of tinnitus, sedation … The findings for sedation were inconsistent and imprecise, as estimates of affected patients were poorly … characterized; the SOE for sedation was insufficient in patients with tinnitus. 7 Table B.

50. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update--Executive Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
    January 01, 2018 - FGAs are mainly associated with dry mouth, sedation, and extrapyramidal symptoms, which are movement … cause adverse effects including weight gain, high triglyceride levels, extrapyramidal symptoms, sedation … There may be little or no difference between classes for sedation. … • Sedation. … There may be little or no difference between olanzapine and risperidone for risk of sedation.

51. Snoring | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/snoring
    Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

52. Off-Label Use of Atypical Antipsychotics: An Update | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/atypical-antipsychotics-off-label-update/research
    March 01, 2020 - In nonelderly adults, adverse events included weight gain (particularly with olanzapine), fatigue, sedation

53. Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacological Interventions (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
    April 15, 2021 - In discussing the potential for adverse effects with brexanolone, sedation and loss of consciousness

54. Comparative Effectiveness of Treatments for Restless Legs Syndrome | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/restless-legs/research-protocol
    December 01, 2019 - Ritigotine Neupro® Sedative-hypnotics Clonazepam Rivotril® Tolerance; sedation … Pregabalin Lyrica® Opioids Hydrocodone -Vicodin® -Lortab® Sedation

55. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
    March 01, 2022 - There may be a large increased risk of dizziness and sedation, and a moderate increased risk of nausea … high THC to CBD) may be associated with moderate improvement in pain severity and increased risk of sedation … no effect on overall function/disability (SOE: low; 2 RCTs) Harms: moderate increased risk of sedation … Combined THC/CBD may also be associated with a moderate to large increased risk of dizziness, sedation … Sedation for comparable THC to CBD ratio versus placebo (short-term, 4 weeks to 6 months followup)

56. Prescription Drug Abuse | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/health-topics/prescription-drug-abuse
    November 27, 2017 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

57. Restless-Legs Research-Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
    December 16, 2011 - Mirapex ® Yes Ritigotine Neupro ® Sedative- hypnotics Clonazepam Rivotril ® Tolerance; sedation … Gabapentin Neurontin ® Pregabalin Lyrica ® Opioids Hydrocodone -Vicodin ® -Lortab ® Sedation

58. Cannabis-2022-Surv-Rep-3-Table-F5 (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
    January 01, 2022 - C Sedation 3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55), RR 0.57 (95% CI 0.35 to 0.93 for A … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

59. Cannabis-2022-Update-Surv-Rep-1-App-F-5 (xls file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
    January 01, 2022 - C Sedation 3 months: 31% (15/49) vs. 54% (28/52) vs. 33% (18/55), RR 0.57 (95% CI 0.35 to 0.93 for A … 1.29 (95% CI 0.75 to 2.21) Nausea: 16.7% (36/215) vs. 9.7% (21/216), RR 1.72 (95% CI 1.04 to 2.85) Sedation

60. Autism-Update Clinician (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
    September 01, 2014 - .  Harms � Aripiprazole and risperidone are associated with significant weight gain, sedation,